For DOTA/NOTA derivatization, 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) or 1,4,7-triazacyclononane-triacetic acid (NOTA) (1 equiv) was preactivated for 20 min using N-hydroxysuccinimide (NHS) (1.25 equiv), 1-ethyl-3- 3-dimethylaminopropyl carbodiimide (EDCI) (1-ethyl-3- 3-dimethylaminopropyl carbodiimide 1-ethyl-3- 3-dimethylaminopropyl carbodiimide
NOTA, 1,4,7-triazacyclononane-1,4,7-triacetic acid; Ki, inhibition constant.
Complexation properties were comparable to the ligand NOTA (1,4,7-triazacyclononane-1,4,7-triacetic acid) (Schmidtke et al. 2017).
In addition Passah et al. reported the use of a bisphosphonate conjugated to NOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) chelator to detect bone metastases efficiently (Passah et al. 2014; Pfannkuchen et al. 2015).
In contrast, DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid), NOTA (1,4,7-triazacyclononane-1,4,7-triacetic acid), and their derivatives (Fig. 2) have been widely used for 68Ga/64Cu-labeling 68Ga/64Cu-labelinge tofthe high hydrophilicity and in vivo stabiomoleculess 68Ga/64Cu chelates (Andueson etoal. 2003; Maecke ethel. 2005; Shighen and Anderson 2009).
Ethical clearance for sampling of animals and interviewing of human subjects was granted on 7 February 2011 by the Ministry of Health, Kaduna State (Nota MOH/HS/PER/VOL.I/234/70).
HB is a junior livestock researcher at UoG. SW is group leader of the Neglected Zoonoses Research Group at UoE. Ethical clearance for interviewing of human subjects was granted on 7 February 2011 by the Ministry of Health, Kaduna State (Nota MOH/HS/PER/VOL.I/234/70).
Amino group termination covalently attached to GO via a six-arm branched glycol (PEG; 10 kDa) chains were conjugated to NOTA (1,4,7-triazacyclononane-1,4,7-triacetic acid, for Ga-labeling) and TRC105 (an antibody that binds to CD105) (Hong et al. 2012), and study of histology validated the characterization of the GO conjugates.
Additionally, we have examined the potential of PACE4 for molecular imaging of prostate cancer using positron-emission tomography (PET) and a ML peptide conjugated to a NOTA (1,4,7-triazacyclononane-1,4,7-triacetic acid) chelating group [ 12] for radiometal labeling with copper-64 (Cu).
Our findings are consistent with Trifirò et al. [ 37] that reported a significant decrease in the utilization of statin after the Nota 13 change in a general practice in southern Italy.
Pancreas uptake were respectively 18.4 ± 2.9, 15.6 ± 2.0 and 57 ± 16%ID/g for NOTA-monomer, NOTA-dimer 1 and NOTA-dimer 2. NOTA-dimer 2 exhibits a 3.6-fold higher pancreas uptake than NOTA-monomer and NOTA-dimer 1. Figure 6 Biodistributions of 64 Cu-labeled NOTA-monomer, NOTA-dimer 1 and NOTA-dimer 2. Biodistributions are at 0.5 h post-injection in Balb/c female mice (four mice/group).
